Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-02-27
2007-02-27
Rawlings, Stephen L. (Department: 1643)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S325000, C530S350000
Reexamination Certificate
active
09367496
ABSTRACT:
The invention concerns a purified polypeptide, biologically active polypeptide derivative or fragment of said purified polypeptide, comprising an amino acid sequence selected among SEQ.ID. No. 2, No. 4, No. 6 and No. 8.
REFERENCES:
patent: 5770381 (1998-06-01), MacKay et al.
patent: 6066475 (2000-05-01), Maclaren et al.
patent: 6455267 (2002-09-01), Tobin et al.
Hamajima, N, et al, Nov. 21, 1996, A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution, Gene, vol. 180, No. 1-2, pp. 157-163.
Honnorat, J, et al, 1996, Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes, Journal of Neurology, Neurosurgery, and Psychiatry, vol. 61, No. 3, pp. 270-278.
Antoine, JC, et al, 1993, Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina, Journal of Neurological Sciences, vol. 117, pp. 215-223.
Database GenBank Accession No. Y10976, Direct Submission (Byk, T, et al, Feb. 3, 1997), H. sapiens mRNA for Ulip4 protein.
Gura, T, 1997, Systems for identifying drugs are often faulty, Science, vol. 278, pp. 1041-1042.
Bodey, B, et al, 2000, Failure of cancer vaccines: the significant limitations of this approach to immunotherapy, Anticancer Research, vol. 20, pp. 2665-2676.
Ezzell, C, 1995, Cancer “vaccines”: an idea whose time has come?, Journal of NIH Research, vol. 7, pp. 46-49.
Bergers, G, et al, 2000, Extrinsic regulators of epithelial tumor progression: metalloproteinases, Current Opinion in Genetics & Development, vol. 10, pp. 120-127.
Splitler, LE, 1995, Cancer vaccines: the interferon analogy, Cancer Biotherapy, vol. 10, No. 1, pp. 1-3.
Tockman, MS, et al, 1992, Considerations in bringing a cancer biomarker to clinical application, Cancer Research, vol. 52, Suppl., pp. 2711s-2718s.
Database GenBank Accession No. AB006713, Hamajima N, Aug. 23, 1997 (see USPTO search report US-09-367-496-8.std.rge, pp. 1 and 2).
Okajima T, et al. J Biochem (Tokyo) May 1995; 117 (5):980-6.
Stefano JE. Cell Jan. 1984; 36 (1): 145-54.
Holmes EH. Exp Opin Invest Drugs 2001; 10 (3): 511-9.
Antoine JC, et al. J Neurol Neurosurg Psychiatry. Jul. 1999; 67 (1): 7-14.
Greenspan NS, et al. Nat Biotechnol. Oct. 1999; 17 (10): 936-7.
Burgess WH, et al. J Cell Biol. Nov. 1990; 111(5 Pt 1):2129-38.
Lazar E, et al. Mol Cell Biol. Mar. 1988; 8 (3): 1247-52.
Houdebine LM. J Biotechnol. May 31, 1994; 34 (3): 269-87.
Verma IM, et al. Nature. Sep. 18, 1997; 389 (6648): 239-42.
Patterson AP, Memorandum (Jan. 14, 2003); pp. 3.
Pandha HS, et al. Cur Opin Invest Drugs. 2000; 1 (1): 122-34.
Amalfitano A, et al. Cur Gene Ther. 2002; 2: 111-33.
Rogemond V, et al. Clin Rev Allergy Immunol. Aug. 2000; 19 (1): 51-9.
Honnorat J, et al. Eur. J. Neurosci. Dec. 1999; 11 (12): 4226-32.
Thompson D, et al. Biotechniques. May 1992; 12 (5): 656-8.
Aguera Michèle
Antoine Jean-Christophe
Aunis Dominique
Belin Marie-Françoise
Byk Tamara
Institut National de la Sante et de la Recherche Medicale (INSER
Rawlings Stephen L.
Schulman B. Aaron
Stites & Harbison PLLC
LandOfFree
Use of ULIP proteins in the diagnosis and therapy of cancers... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ULIP proteins in the diagnosis and therapy of cancers..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ULIP proteins in the diagnosis and therapy of cancers... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3823903